German pharmaceutical company BioNTech, which is currently developing a possible vaccine against the novel coronavirus together with US drug giant Pfizer, announced Thursday it was buying a new production plant in order drastically to increase its production capacities.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push